1 Geras Audra J., S.G.R.a.H.W. (1990) Dermatology- A medical artist's interpretetion , Sandez Pharma ltd

2 Berthod, F.a.R., M. (1997) In Skin substitute production by tissue engineering: clinical and fundamental applications , pp. 23-45, R,G Landes Biosciences

3 Adams, J.C. and Watt, F.M. (1993) Regulation of development and differentiation by the extracellular matrix. Development 117 (4), 1183-1198

4 Tooze, C.B.J. (1999) Introduction to protein structure , Garland

5 Germain, L., Xu, W., Michel M., Fradette, J., Godbout, M-J., Li, H. (1997). Skin Stem Cell Identification and culture: A potential tool for rapid epidermal sheet production and grafting. (Chapter 8); Skin substitute production by tissue engineering: Clinical and fundamental applications ; Rouabhia, M. Landes, Austin, Texas, USA. 176-210

6 Lodish, B., Zipursky, Matsudaira, Baltimore, Darnell. (1999) Molecular cell biology, 4th edition , Freeman

7 Cohen, I.K. et al. (1992) Wound healing : biochemical & clinical aspects. In Wound healing : biochemical & clinical aspects , pp. xxv, 630, W.B. Saunders Co.

8 Stringer, S.E. and Gallagher, J.T. (1997) Heparan sulphate. Int J Biochem Cell Biol 29 (5), 709-714

9 Ruoslahti, E. (1989) Proteoglycans in cell regulation. J Biol Chem 264 (23), 13369-13372

10 Perrimon, N. and Bernfield, M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404 (6779), 725-728

11 Izvolsky, K.I. et al. (2003) Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol 258 (1), 185-200

12 Ruoslahti, E. and Yamaguchi, Y. (1991) Proteoglycans as modulators of growth factor activities. Cell 64 (5), 867-869

13 Saksela, O. et al. (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107 (2), 743-751

14 Damon, D.H. et al. (1989) Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life. J Cell Physiol 138 (2), 221-226

15 Gospodarowicz, D. and Cheng, J. (1986) Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128 (3), 475-484

16 Rosengart, T.K. et al. (1988) Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Biochem Biophys Res Commun 152 (1), 432-440

17 Gallagher, J.T. (2001) Heparan sulfate: growth control with a restricted sequence menu. J Clin Invest 108 (3), 357-361

18 Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110 (6), 673-687

19 Bode, W. et al. (1999) Structural properties of matrix metalloproteinases. Cell Mol Life Sci 55 (4), 639-652

20 Sternlicht, M.D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17, 463-516

21 Barrandon, Y. (1998) Biologie des cellules souches épidermique (adaptation de la communication originale). Ann Dermatol Venereol 125 Suppl 2, S5-6.

22 Sun, T.T. et al. (1983) Keratin classes: molecular markers for different types of epithelial differentiation. J Invest Dermatol 81 (1 Suppl), 109s-115s

23 Sun, T.T. et al. (1983) Keratin expression during normal epidermal differentiation. Curr Probl Dermatol 11, 277-291

24 Cotsarelis, G. et al. (1999) Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol 8 (1), 80-88

25 Chinen, N. et al. (2003) Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J Biomed Mater Res 67A (1), 61-68

26 Michel, M. et al. (1996) Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. J Cell Sci 109 (Pt 5), 1017-1028.

27 Pellegrini, G. et al. (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 98 (6), 3156-3161.

28 Laplante, A.F. et al. (2001) Mechanisms of wound reepithelialization: hints from a tissue-engineered reconstructed skin to long-standing questions. Faseb J 15 (13), 2377-2389.

29 Meddahi, A. et al. (1995) Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation. Biochimie 77 (9), 703-706

30 Meddahi, A. et al. (1996) FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int J Biol Macromol 18 (1-2), 141-145

31 Mestries, P. et al. (2001) Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta1. Matrix Biol 20 (3), 171-181.

32 Ledoux, D. et al. (2000) Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem 275 (38), 29383-29390.

33 Ledoux, D. et al. (2003) Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. FEBS Lett 537 (1-3), 23-29

34 Meddahi, A. et al. (2002) Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration. J Biomed Mater Res 62 (4), 525-531

35 Fredj-Reygrobellet, D. et al. (1994) CMDBS, functional analogue of heparin sulfate as a new class of corneal ulcer healing agents. Ophthalmic Res 26 (6), 325-331

36 Meddahi, A. et al. (1994) New approaches to tissue regeneration and repair. Pathol Res Pract 190 (9-10), 923-928

37 Meddahi, A. et al. (1996) New concepts in tissue repair: skin as an example. Diabetes Metab 22 (4), 274-278

38 Aamiri, A. et al. (1995) [Effects of substituted dextran on reinnervation of a skeletal muscle in adult rats during regeneration]. C R Acad Sci III 318 (10), 1037-1043

39 Blanquaert, F. et al. (1995) Heparan-like molecules induce the repair of skull defects. Bone 17 (6), 499-506.

40 Yamauchi, H. et al. (2000) New agents for the treatment of infarcted myocardium. Faseb J 14 (14), 2133-2134

41 Meddahi, A. et al. (1996) Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage. J Biomed Mater Res 31 (3), 293-297

42 Meddahi, A. et al. (2002) Heparin-like polymer improved healing of gastric and colic ulceration. J Biomed Mater Res 60 (3), 497-501

43 Morvan, F.O. et al. (2004) An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamsters. Am J Pathol 164 (2), 739-746

44 Escartin, Q. et al. (2003) A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. Faseb J 17 (6), 644-651

45 Tardieu, M. et al. (1992) Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF. J Cell Physiol 150 (1), 194-203

46 Mestries, P. et al. (1998) Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboxymethyl, benzylamide, and sulfation substitutions. J Biomed Mater Res 42 (2), 286-294

47 Benazzoug, Y. et al. (1995) Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem Pharmacol 49 (6), 847-853

48 Logeart, D. et al. (1996) Collagen synthesis by vascular smooth muscle cells in the presence of antiproliferative polysaccharides. J Biomed Mater Res 30 (4), 501-508

49 Alexakis, C. et al. (2001) Heparan mimetic regulates collagen expression and TGF-beta1 distribution in gamma-irradiated human intestinal smooth muscle cells. Faseb J 15 (9), 1546-1554

50 Stockholm, D. et al. (1999) Studies on calpain expression during differentiation of rat satellite cells in primary cultures in the presence of heparin or a mimic compound. Exp Cell Res 252 (2), 392-400

51 Papy-Garcia, D. et al. (2002) Glycosaminoglycan mimetics (RGTA) modulate adult skeletal muscle satellite cell proliferation in vitro. J Biomed Mater Res 62 (1), 46-55

52 Blanquaert, F. et al. (1999) Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res 44 (1), 63-72

53 Blanquaert, F. et al. (2003) RGTA modulates the healing pattern of a defect in a monolayer of osteoblastic cells by acting on both proliferation and migration. J Biomed Mater Res 64A (3), 525-532

54 Green, H. et al. (1979) Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A 76 (11), 5665-5668

55 Germain, L. et al. (1993) Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19 (2), 99-104

56 Gallico, G.G., 3rd et al. (1984) Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl J Med 311 (7), 448-451

57 Clugston, P.A. et al. (1991) Cultured epithelial autografts: three years of clinical experience with eighteen patients. J Burn Care Rehabil 12 (6), 533-539

58 Donati, L. et al. (1992) Clinical experiences with keratinocyte grafts. Burns 18 Suppl 1, S19-26

59 Gallico, G.G., 3rd and O'Connor, N.E. (1985) Cultured epithelium as a skin substitute. Clin Plast Surg 12 (2), 149-157

60 De Luca, M. et al. (1989) Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 15 (5), 303-309

61 Desai, M.H. et al. (1991) Lack of long-term durability of cultured keratinocyte burn-wound coverage: a case report. J Burn Care Rehabil 12 (6), 540-545

62 Vaughan, F.L. et al. (1986) Growth and differentiation of primary rat keratinocytes on synthetic membranes. In Vitro Cell Dev Biol 22 (3 Pt 1), 141-149

63 Lee, S.H. and Tseng, S.C. (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123 (3), 303-312

64 Boyce, S.T. et al. (1988) Structure of a collagen-GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 22 (10), 939-957

65 Auger, F.A. et al. (1995) Skin equivalent produced with human collagen. In Vitro Cell Dev Biol Anim 31 (6), 432-439

66 Horch, R.E. et al. (2000) Cultured human keratinocytes on type I collagen membranes to reconstitute the epidermis. Tissue Eng 6 (1), 53-67

67 Ronfard, V. et al. (1991) Use of human keratinocytes cultured on fibrin glue in the treatment of burn wounds. Burns 17 (3), 181-184

68 Pellegrini, G. et al. (1999) The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. Transplantation 68 (6), 868-879

69 Han, B. et al. (2002) A fibrin-based bioengineered ocular surface with human corneal epithelial stem cells. Cornea 21 (5), 505-510

70 Ronfard, V. et al. (2000) Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 70 (11), 1588-1598

71 Coulomb, B. et al. (1986) A new method for studying epidermalization in vitro. Br J Dermatol 114 (1), 91-101

72 Hettich, R. (1986) Interactions between local and generalised burn edema. Resuscitation 14 (1-2), 105-112

73 Meana, A. et al. (1998) Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns 24 (7), 621-630

74 Hafemann, B. et al. (1994) Treatment of skin defects using suspensions of in vitro cultured keratinocytes. Burns 20 (2), 168-172

75 Rama, P. et al. (2001) Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency. Transplantation 72 (9), 1478-1485

76 Lee, K.H. (2000) Tissue-engineered human living skin substitutes: development and clinical application. Yonsei Med J 41 (6), 774-779

77 Michel, M. et al. (1999) Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 35 (6), 318-326.

78 Berk, B.C. et al. (1991) Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. J Am Coll Cardiol 17 (6 Suppl B), 111B-117B

79 Asselot-Chapel, C. et al. (1995) Expression of fibronectin and interstitial collagen genes in smooth muscle cells: modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol 49 (5), 653-659

80 Barrandon, Y. et al. (1988) New techniques for the grafting of cultured human epidermal cells onto athymic animals. J Invest Dermatol 91 (4), 315-318

81 Auger, F.A. et al. (1993) Role and innocuity of Tisseel, a tissue glue, in the grafting process and in vivo evolution of human cultured epidermis. Br J Plast Surg 46 (2), 136-142

82 Germain, L. et al. (1999) Reconstructed human cornea produced in vitro by tissue engineering. Pathobiology 67 (3), 140-147.